Oncology Panel 10 Gb/sample (5000x.1 Mb panel)

An oncology panel is a type of genetic test that analyzes a set of genes known to be associated with cancer development and progression. The panel typically includes genes that are commonly mutated in various types of cancer, including tumor suppressor genes, oncogenes, and genes involved in DNA repair and cell cycle regulation.

Oncology panels can be designed using different sequencing technologies, including targeted sequencing, which focuses on specific regions of the genome, or whole exome sequencing, which sequences all protein-coding regions of the genome. The resulting sequence data can be analyzed to identify mutations, small insertions or deletions, and copy number variations in the genes included in the panel.

Oncology panels are used in clinical settings to help diagnose and guide treatment decisions for various types of cancer. The information obtained from the panel can inform prognosis, identify potential therapeutic targets, and predict response to specific treatments.

Oncology panels can also be used in research settings to investigate the genetic basis of cancer and identify new targets for cancer therapy.

Oncology panels are a powerful tool for personalized cancer care, providing clinicians and researchers with valuable information about the genetic alterations driving cancer development and progression.